CES3 and nonpapillary renal cell carcinoma: We utilized a pair of isogenic ccRCC cell lines derived from SKRC-42 (BAP1 null) to validate our observation regarding CES3. First, we confirmed the BAP1 status of these lines using a western blot (Fig. 7e).